Thursday, March 28, 2024 1:08:26 AM
Held at DTC 251,568,859 03/22/2024
https://www.otcmarkets.com/stock/KNOS/security
In connection with the appointment of Greg Rubin as Chairman of the Board and Interim CEO, the Company provides the following information about Mr. Rubin:
Greg Rubin is a serial entrepreneur and investor with over 35 years of business experience in various sectors, such as oil and gas, energy, technology, biotechnology, healthcare and blockchain. He holds multiple patents and co-authored a bestselling book on Health and Wellness. He is also a subject matter expert who has appeared on various media platforms to share his insights and analysis.
He is currently the CEO of KronosMD Inc., where he leads the development and manufacturing of an advanced medical and dental 3D ultrasound imaging technology powered by AI. He is passionate about creating innovative solutions that improve the quality and accessibility of healthcare. He is driven by the vision of empowering people and businesses with the benefits of decentralized and distributed systems.
Mr. Rubin plans to enhance operational efficiency, foster innovation, and explore emerging market opportunities to drive growth and expand the company's presence in diverse markets.
Pursuant to the requirements of the Securities Exchange Act of 1933, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.
Statement from Greg Rubin:
As Interim CEO and Chairman of Kronos Advanced Technologies, I am thrilled to assume responsibilities as the Company’s new management. The establishment of our medical device manufacturing subsidiary, KronosMD Inc. marked a significant milestone in Kronos' journey as we expand our focus to include precision medical components and medical device manufacturing.
The formation of KronosMD Inc. underscored our commitment to leveraging our expertise in precision healthcare manufacturing to explore opportunities in the rapidly growing medical devices and precision medical component markets. This initiative aligns seamlessly with Kronos' 2024 strategy, reflecting our dedication to innovation and growth.
The medical device and new medical technologies market are experiencing exponential growth, driven by factors such as the rising prevalence of chronic diseases and an aging population. As we venture into this exciting new area, Kronos is well-positioned to add immediate shareholder value by utilizing our scale and manufacturing capabilities to deliver innovative, high-quality solutions to the market.
KronosMD™ represents a natural extension of Kronos' core capabilities in electronics manufacturing and supply chain management. By offering domestic contract manufacturing solutions, we aim to address the evolving needs of today's consumers and contribute to the advancement of healthcare technologies.
Since our inception in 2002, Kronos Advanced Technologies has been at the forefront of innovation, revolutionizing the way air is moved, filtered, and sterilized. Our patented technology has been instrumental in various sectors, including indoor air quality, automotive, and healthcare.
https://www.otcmarkets.com/filing/html?id=17340919&guid=kpd-knY5SRD-drh
Recent KNOS News
- Form 8-K - Current report • Edgar (US Regulatory) • 03/05/2024 05:59:31 PM
- Form C-AR - Annual Report • Edgar (US Regulatory) • 10/30/2023 06:02:12 PM
- Form 1-A/A - Offering Statement [Regulation A]: [Amend] • Edgar (US Regulatory) • 10/10/2023 02:06:27 PM
Bantec Engaged in a Letter of Intent to Acquire a Small New Jersey Based Manufacturing Company • BANT • May 1, 2024 10:00 AM
Cannabix Technologies to Deliver Breath Logix Alcohol Screening Device to Australia • BLO • Apr 30, 2024 8:53 AM
Hydromer, Inc. Reports Preliminary Unaudited Financial Results for First Quarter 2024 • HYDI • Apr 29, 2024 9:10 AM
Avant Technologies to Implement AI-Empowered, Zero Trust Architecture in Its Data Centers • AVAI • Apr 29, 2024 8:00 AM
Bantec Reports an Over 50 Percent Increase in Sales and Profits in Q1 2024 from Q1 2023 • BANT • Apr 25, 2024 10:00 AM
Cannabix's Breath Logix Alcohol Device Delivers Positive Impact to Private Monitoring Agency in Montana, USA • BLO • Apr 25, 2024 8:52 AM